十大电竞直播手机app

  • Previous Nav

  • Net Change on 09-09-2022

  • 十大电竞(广州)最新版登录正规 Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI -0.22 5.25 -12.06 21.96 12.77 13.71

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 -10.06 25.52 18.43 1.06 4,587.75
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 -6.70 25.82 13.74 1.07 1,675.44
UTI Healthcare Fund - Direct Plan - IDCW Jan 01, 2013 -10.98 24.33 14.22 1.42 713.11
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 -7.84 24.29 17.19 0.99 519.10
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 -7.84 24.29 17.19 0.99 519.10

Fund Holdings as on 31-August-2022

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Dr. Reddys Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Divi's Laboratories Limited

  • Torrent Pharmaceuticals Limited

  • Fortis Healthcare Limited

  • Aurobindo Pharma Limited

  • Alkem Laboratories Limited

  • Clearing Corporation of India Limited

  • Lupin Limited

  • Ajanta Pharmaceuticals Limited

  • Indoco Remedies Limited

  • J.B. Chemicals & Pharmaceuticals Limited

  • Sanofi India Limited

  • Eris Lifesciences Limited

  • Abbott India Limited

  • IPCA Laboratories Limited

  • Gland Pharma Limited

  • Zydus Wellness Limited

  • Medplus Health Services Limited

  • Biocon Limited

  • METROPOLIS HEALTHCARE LIMITED

  • Strides Pharma Science Limited

  • Tarsons Products Limited

  • Vijaya Diagnostic Centre Limited

  • Natco Pharma Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Solara Active Pharma Sciences Limited

  • Net Receivables / (Payables)

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Consumer Food

  • Plastic Products

View More

About Aditya Birla Sun Life Pharma & Healthcare Fund

Scheme Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund . It was launched on 10-Jul-2019 and currently has an AUM of ₹475.63 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended up ₹0 (0%) yesterday to ₹15.44 .

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .

Fund House Contact

One India Bulls Centre , Tower 1, 17th Floor, Jupiter Mill Compound, 841, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111
英雄联盟竞猜赛事在线永久 fifa电竞(长春)手游外围1.4.10 gtv电竞比赛数据 大圣电竞数据APP v2.3 esg电竞比分详情 lpl电竞比赛排名官网